Related Experiment Videos
Intra-aortic balloon pump: a perspective
Insights
Coronary care units reduced acute myocardial infarction mortality. The intra-aortic balloon pump (IABP) shows promise in treating cardiogenic shock and potentially reducing infarct size.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Acute myocardial infarction mortality has decreased due to coronary care units and early arrhythmia management.
- Congestive heart failure and cardiogenic shock remain significant causes of mortality post-infarction.
Purpose of the Study:
- To review the role of mechanical circulatory assistance, specifically the intra-aortic balloon pump (IABP), in managing acute myocardial infarction complications.
- To explore expanded and future applications of IABP in cardiovascular care.
Main Methods:
- Review of available clinical evidence on the efficacy of intra-aortic balloon pump (IABP) in patients with acute myocardial infarction.
- Analysis of current and potential therapeutic roles of IABP in managing refractory unstable angina, post-infarction ischemic pain, and cardiogenic shock.
Main Results:
- Intra-aortic balloon pump (IABP) has demonstrated effectiveness in reversing cardiogenic shock.
- IABP is increasingly used for unstable angina and post-infarction ischemic pain refractory to medical treatment.
Conclusions:
- The intra-aortic balloon pump (IABP) is a valuable tool in managing severe acute myocardial infarction complications.
- Future applications may involve earlier IABP implementation and its use in limiting myocardial infarct size.
Abstract:
The mortality from acute myocardial infarction has declined 14-18 percent since the advent of coronary care units. This decline has been attributed to the early detection and prophylactic treatment of cardiac arrhythmias and conduction disturbances. Infarction complicated by congestive heart failure and cardiogenic shock accounts for major residual mortality. Available evidence in man have shown reversal of cardiogenic shock with the use of mechanical circulatory assistance via the intra-aortic balloon pump (IABP). Expanded IABP use now includes unstable angina refractory to medical therapy and post infarction ischemic pain. Future roles of IABP include its earlier use in the management of complicated myocardial infarction, as well as a modality useful in reducing myocardial infarction size.